Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from Prograf to modified-release tacrolimus in stable adult liver transplant recipients
2006-000936-28Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tacrolimus in liver transplant, sponsored by Astellas Pharma. Primary endpoints: Change in creatinine clearance and Safety. Started Jun 2006; status: completed.
02
Drugs
tacrolimus
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2006-000936-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000936-28.